Related Experiment Video
Updated: Aug 4, 2026

09:03
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Developing a national system for dealing with adverse events following immunization
U Mehta1, J B Milstien, P Duclos
1National Adverse Drug Event Monitoring Centre, University of Cape Town, Observatory, South Africa. umehta@uctgsh1.uct.ac.za
Bulletin of the World Health Organization
|April 1, 2000
Summary
Establishing robust national vaccine safety monitoring and reporting systems is crucial for public health. This includes efficient coordination with pharmaceutical safety systems and public communication strategies for adverse events.
Area of Science:
- Public Health
- Pharmaceutical Safety
- Vaccinology
Background:
- Vaccines are generally safe, but severe adverse events can pose public health threats.
- Existing pharmaceutical safety monitoring may not adequately address vaccine-specific concerns.
- Public trust and rapid risk assessment are vital during adverse event investigations.
Purpose of the Study:
- To outline a simple national system for managing vaccine safety and emergencies.
- To describe the goals of a training program for developing such a system.
- To enhance global vaccine safety surveillance capabilities.
Main Methods:
- The World Health Organization (WHO) Global Training Network developed a national system framework.
- The framework focuses on simple, coordinated monitoring and reporting mechanisms.
- Training program goals were defined to support system implementation.
Main Results:
- A model for a national vaccine safety and emergency management system was described.
- Key components for training programs to build these systems were identified.
- Emphasis was placed on integrating vaccine safety with broader pharmaceutical safety.
Conclusions:
- Effective national systems are essential for managing vaccine safety and public concerns.
- Coordinated monitoring and reporting are critical for timely risk assessment.
- Training initiatives can strengthen a nation's capacity to ensure vaccine safety.
Related Concept Videos
Vaccinations
Overview
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.

